Alliance for Pandemic Preparedness
August 26, 2020
Hydroxychloroquine in the Treatment of Outpatients with Mildly Symptomatic COVID-19 A Multi-Center Observational Study
Category: Article Summary
Topic: Testing and Treatment
Keywords (Tags): treatment
- [pre-print, not peer-reviewed] In a retrospective observational study of SARS-CoV-2 infected non-hospitalized patients (n=1,274), hydroxychloroquine exposure was associated with a decreased rate of hospitalization from COVID-19 in a 1,067 patient propensity score matched cohort (OR=0.53, 95%CI 0.29, 0.95). Among outpatients treated with hydroxychloroquine 22% with were hospitalized compared to 32% who did not receive hydroxychloroquine.
Ip et al. (Aug 25, 2020). Hydroxychloroquine in the Treatment of Outpatients with Mildly Symptomatic COVID-19 A Multi-Center Observational Study. Pre-print downloaded Aug 26 from https://doi.org/10.1101/2020.08.20.20178772